GANX · Gain Therapeutics, Inc.
$1.91
-0.10 (-4.75%)
At close · Aug 25
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our projected cash outflows for the upcoming periods raise substantial doubt about our ability to continue as a going concern for at least 12 months from the issuance of the financial statements included elsewhere in this Quarterly Report.”View the 10-Q filed Aug 11, 2026
Market Cap
$87.51M
Shares
43.64M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-20 | 206,286 | 1,340,689 | 1,546,975 | 67.4% |
| 2026-07-13 | 304,511 | 2,464,150 | 2,768,661 | 57.6% |
| 2026-07-06 | 247,026 | 1,660,724 | 1,907,750 | 60.4% |
| 2026-06-29 | 630,839 | 8,101,806 | 8,732,645 | 46.9% |
| 2026-06-22 | 182,685 | 1,235,260 | 1,417,945 | 62.1% |
| 2026-06-15 | 111,508 | 1,064,776 | 1,176,284 | 60.8% |
| 2026-06-08 | 338,701 | 1,467,619 | 1,806,320 | 55.9% |
| 2026-06-01 | 242,471 | 1,932,562 | 2,175,033 | 63.9% |
| 2026-05-25 | 395,233 | 2,255,470 | 2,650,703 | 61.7% |
| 2026-05-18 | 240,310 | 1,740,698 | 1,981,008 | 61.9% |
| 2026-05-11 | 170,062 | 1,240,871 | 1,410,933 | 62.5% |
| 2026-05-04 | 175,013 | 1,301,697 | 1,476,710 | 68.8% |
| 2026-04-27 | 279,076 | 1,415,301 | 1,694,377 | 61.1% |
| 2026-04-20 | 215,836 | 1,194,761 | 1,410,597 | 54.9% |
| 2026-04-13 | 317,621 | 1,747,380 | 2,065,001 | 63.5% |
| 2026-04-06 | 355,621 | 1,004,489 | 1,360,110 | 52.8% |
| 2026-03-30 | 225,011 | 857,923 | 1,082,934 | 55.6% |
| 2026-03-23 | 273,555 | 1,665,162 | 1,938,717 | 61.0% |
| 2026-03-16 | 434,753 | 2,916,704 | 3,351,457 | 57.3% |
| 2026-03-09 | 377,708 | 2,252,594 | 2,630,302 | 59.2% |
| 2026-03-02 | 314,045 | 1,635,182 | 1,949,227 | 53.8% |
| 2026-02-23 | 651,457 | 2,593,796 | 3,245,253 | 56.0% |
| 2026-02-16 | 155,133 | 913,732 | 1,068,865 | 53.7% |
| 2026-02-09 | 164,514 | 1,024,243 | 1,188,757 | 56.8% |
| 2026-02-02 | 179,877 | 1,591,990 | 1,771,867 | 57.4% |
| 2026-01-26 | 206,418 | 1,399,887 | 1,606,305 | 58.5% |
| 2026-01-19 | 276,627 | 1,830,694 | 2,107,321 | 61.7% |
| 2026-01-12 | 807,824 | 3,451,407 | 4,259,231 | 60.3% |
| 2026-01-05 | 407,206 | 4,522,066 | 4,929,272 | 62.1% |
| 2025-12-29 | 247,891 | 1,624,847 | 1,872,738 | 61.5% |
| 2025-12-22 | 485,159 | 2,790,628 | 3,275,787 | 59.9% |
| 2025-12-15 | 1,646,513 | 13,225,000 | 14,871,513 | 63.1% |
| 2025-12-08 | 1,029,968 | 3,268,770 | 4,298,738 | 57.5% |
| 2025-12-01 | 776,873 | 2,805,952 | 3,582,825 | 57.9% |
| 2025-11-24 | 452,949 | 2,266,789 | 2,719,738 | 61.1% |
| 2025-11-17 | 524,159 | 2,070,347 | 2,594,506 | 57.4% |
| 2025-11-10 | 1,535,874 | 5,820,107 | 7,355,981 | 64.1% |
| 2025-11-03 | 286,469 | 2,356,519 | 2,642,988 | 64.5% |
| 2025-10-27 | 375,954 | 1,731,540 | 2,107,494 | 65.8% |
| 2025-10-20 | 232,565 | 1,848,153 | 2,080,718 | 60.5% |
| 2025-10-13 | 371,320 | 2,142,613 | 2,513,933 | 65.3% |
| 2025-10-06 | 413,680 | 4,964,308 | 5,377,988 | 65.3% |
| 2025-09-29 | 180,374 | 2,023,120 | 2,203,494 | 67.0% |
| 2025-09-22 | 100,226 | 1,996,907 | 2,097,133 | 74.0% |
| 2025-09-15 | 136,247 | 1,909,895 | 2,046,142 | 62.8% |
| 2025-09-08 | 233,049 | 1,462,009 | 1,695,058 | 62.6% |
| 2025-09-01 | 302,266 | 2,518,907 | 2,821,173 | 73.5% |
Showing 1–47 of 47 weeks
Key facts
CIK
1819411
CUSIP
36269B105
13F (30d)
45 filings
45 filers
Visit website
Investor relations